ACCPL — Accretion Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.24bn
- IN₹1.32bn
- IN₹896.27m
Annual cashflow statement for Accretion Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.04 | 1.39 | 57.6 | 97.6 | 131 |
| Depreciation | |||||
| Non-Cash Items | 10.2 | 10.8 | 11.5 | 14.4 | 8.48 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.19 | -18.2 | -90.9 | -62.3 | -298 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 21.5 | 3.21 | -13.3 | 57.5 | -146 |
| Capital Expenditures | -2.57 | -11.8 | -1.08 | -16.1 | -85.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.785 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -2.57 | -11 | -1.08 | -16.1 | -85.3 |
| Financing Cash Flow Items | -10.2 | -10.8 | -11.5 | -14.4 | -8.48 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -15.8 | 4.4 | 14.9 | -41.8 | 271 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.08 | -3.38 | 0.553 | -0.408 | 39.7 |